Viewing Study NCT06910592


Ignite Creation Date: 2025-12-24 @ 3:58 PM
Ignite Modification Date: 2026-01-01 @ 11:00 PM
Study NCT ID: NCT06910592
Status: COMPLETED
Last Update Posted: 2025-09-17
First Post: 2025-03-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: EXOMIND (BTL-995) for Reduction of Binge-eating
Sponsor: BTL Industries Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module